Naomi Gronich, MD, is currently an Assistant Clinical Professor in the Rappaport Faculty of Medicine, Technion – Israel Institute of Technology. Naomi earned her MD degree at the Tel- Aviv University. She is board certified in Internal Medicine after completion of an Internal Medicine Residency in Meir Hospital, Kfar-Saba, Israel; and board certified in Clinical Pharmacology following a 3-years fellowship in the NIH ClinPRAT program, under the mentorship of Dr. Darrell Abernethy, at the National Institute on Aging, Baltimore, Maryland. Since 2008 she is a senior physician at the Department of Community Medicine and Epidemiology at Carmel Medical Center, where she holds a key role in Clalit National Personalized Medicine service. She teaches Clinical Pharmacology to medical students, and serves also as an internist in Carmel Hospital Emergency Department. As part of her pharmacogenetics expertise the Department of Community Medicine and Epidemiology established a project in community clinics in Clalit Haifa District to study the outcomes of implementation of pharmacogenetics tests. She is an author of papers in pharmacogenetics and pharmacoepidemiology, and an author of book chapters in pharmacogeriatrics and chemoprevention. She is a member of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), and served at the Steering Committee of its Pharmacogenomics Community. She is also a member of the Clinical Pharmacogenetics Implementation Consortium since 2015 (an international consortium established by the NIH Pharmacogenomics Research Network (PGRN) to form guidelines for implementation of pharmacogenetic tests); an elected member of the Israeli Society of Clinical Pharmacology Steering Committee; an appointed member of Clalit Personalized Medicine Committee; and of the Pharmacology Consulting Committee to the Israel Ministry of Health.
Naomi Gronich, MD
Rappaport Faculty of Medicine and Carmel Medical Center.
7 Michal St. Haifa, ISRAEL, 3436212
Office: +972-4-8250474, +972-48250558